Emergency Department-based Cervical Cancer Screening Through Self-sampling

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-65
SponsorUniversity of Rochester

About this trial

This project will compare the uptake of cervical cancer screening through ED HPV sampling among patients presenting to the ED.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Cisgender women and transgender/non-binary individuals with a cervix,

Age 30 - 65 years, and demonstrating decisional capacity to consent to participate with no known

Disqualifiers

Past hysterectomy with cervical removal

Known infection with HIV (as screening recommendations for people with HIV differ from the general population)

Inability to consent (e.g., lacking decisional capacity, intoxicated, or in distress)

Current pregnancy or in the three months after giving birth

Trial design

Design model

Single group

Treatments tested in this trial

  • Cervical Cancer Screening

    Diagnostic test

    Subjects will perform self sampling for cervical cancer.

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: Intervention ArmExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Uptake of cervical cancer screening from self-sampling in the ED

Number of subjects referred for additional screening who follow through with next steps in the screening process.

Time frame
In about 150 days of enrollment

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.